Leveraging the Power of a Healthcare System to Fulfill the COVID Convalescent Plasma Needs Early in the COVID-19 Pandemic

[Image: see text] INTRODUCTION Convalescent plasma for the treatment of emerging infectious disease has shown to reduce mortality during the 1918 influenza, 2003 SARS, and 2009 influenza H1N1 pandemics. The overall cumulative COVID-19 hospitalization rate is 130 per 100,000, with up to 50% mortality...

Descripción completa

Detalles Bibliográficos
Autores principales: Baez Sosa, Valentina, Conry-Cantilena, Cathy, Wortmann, Glenn, Fischer, Emily R, Clark, Brandon G, Wyne, Lorraine, Shenoy, Aarthi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
401.Basic Science and Clinical Practice in Blood Transfusion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330163/
http://dx.doi.org/10.1182/blood-2020-138948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330163/
http://dx.doi.org/10.1182/blood-2020-138948

Ejemplares similares